Caring for individuals with a difference of sex development (DSD): a Consensus Statement
Standard
Caring for individuals with a difference of sex development (DSD): a Consensus Statement. / Cools, Martine; Nordenström, Anna; Robeva, Ralitsa; Hall, Joanne; Westerveld, Puck; Flück, Christa; Köhler, Birgit; Berra, Marta; Springer, Alexander; Schweizer, Katinka; Pasterski, Vickie; COST Action BM1303 working group 1.
In: NAT REV ENDOCRINOL, Vol. 14, No. 7, 07.2018, p. 415-429.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Caring for individuals with a difference of sex development (DSD): a Consensus Statement
AU - Cools, Martine
AU - Nordenström, Anna
AU - Robeva, Ralitsa
AU - Hall, Joanne
AU - Westerveld, Puck
AU - Flück, Christa
AU - Köhler, Birgit
AU - Berra, Marta
AU - Springer, Alexander
AU - Schweizer, Katinka
AU - Pasterski, Vickie
AU - COST Action BM1303 working group 1
PY - 2018/7
Y1 - 2018/7
N2 - The term differences of sex development (DSDs; also known as disorders of sex development) refers to a heterogeneous group of congenital conditions affecting human sex determination and differentiation. Several reports highlighting suboptimal physical and psychosexual outcomes in individuals who have a DSD led to a radical revision of nomenclature and management a decade ago. Whereas the resulting recommendations for holistic, multidisciplinary care seem to have been implemented rapidly in specialized paediatric services around the world, adolescents often experience difficulties in finding access to expert adult care and gradually or abruptly cease medical follow-up. Many adults with a DSD have health-related questions that remain unanswered owing to a lack of evidence pertaining to the natural evolution of the various conditions in later life stages. This Consensus Statement, developed by a European multidisciplinary group of experts, including patient representatives, summarizes evidence-based and experience-based recommendations for lifelong care and data collection in individuals with a DSD across ages and highlights clinical research priorities. By doing so, we hope to contribute to improving understanding and management of these conditions by involved medical professionals. In addition, we hope to give impetus to multicentre studies that will shed light on outcomes and comorbidities of DSD conditions across the lifespan.
AB - The term differences of sex development (DSDs; also known as disorders of sex development) refers to a heterogeneous group of congenital conditions affecting human sex determination and differentiation. Several reports highlighting suboptimal physical and psychosexual outcomes in individuals who have a DSD led to a radical revision of nomenclature and management a decade ago. Whereas the resulting recommendations for holistic, multidisciplinary care seem to have been implemented rapidly in specialized paediatric services around the world, adolescents often experience difficulties in finding access to expert adult care and gradually or abruptly cease medical follow-up. Many adults with a DSD have health-related questions that remain unanswered owing to a lack of evidence pertaining to the natural evolution of the various conditions in later life stages. This Consensus Statement, developed by a European multidisciplinary group of experts, including patient representatives, summarizes evidence-based and experience-based recommendations for lifelong care and data collection in individuals with a DSD across ages and highlights clinical research priorities. By doing so, we hope to contribute to improving understanding and management of these conditions by involved medical professionals. In addition, we hope to give impetus to multicentre studies that will shed light on outcomes and comorbidities of DSD conditions across the lifespan.
KW - Journal Article
KW - Review
U2 - 10.1038/s41574-018-0010-8
DO - 10.1038/s41574-018-0010-8
M3 - SCORING: Journal article
C2 - 29769693
VL - 14
SP - 415
EP - 429
JO - NAT REV ENDOCRINOL
JF - NAT REV ENDOCRINOL
SN - 1759-5029
IS - 7
ER -